Molina Healthcare is projected to report a 60.9% earnings decline in Q3 2026 with revenues falling 4.8%. The company faces multiple headwinds including a 12.7% membership decline (63% drop in Marketplace enrollment), rising medical care ratio to 93%, and falling premium revenues and investment income. The stock has a negative Earnings ESP of -3.30% and Zacks Rank #4 (Sell), making an earnings beat unlikely.

Elevance Health is projected to report Q3 2026 earnings on October 21, 2026, with consensus estimates showing a 22.7% year-over-year EPS decline to $4.66 per share and a 3% revenue decrease. The company faces challenges from declining premiums (-4.9%), reduced Commercial Individual and Medicaid membership, and a significant 23.9% plunge in Health Benefits operating income. Despite these headwinds, total expenses are expected to decline 5.5%, providing some offset.

Aveanna Healthcare Holdings Inc. (AVAH) is drawing attention from options traders due to high implied volatility in its December 2026 $2.50 put options, suggesting market expectations for significant price movement. Despite the volatility, the company maintains a Zacks Rank #2 (Buy) rating with recent analyst upgrades to earnings estimates, indicating a potentially developing trade opportunity.

Aveanna Healthcare (AVAH) is highlighted as a compelling value stock opportunity, holding a Zacks Rank #2 (Buy) rating and an 'A' grade for Value. The stock trades at a Forward P/E of 17.55, below its industry average of 18.43, and demonstrates attractive valuation metrics across P/S and P/CF ratios, suggesting it may be undervalued relative to its earnings outlook.

Aveanna Healthcare (AVAH), a home health care services provider, is highlighted as a stock likely to beat earnings estimates in its upcoming report. The company has a track record of beating earnings in the last two quarters with an average surprise of 33.94%. With a positive Earnings ESP of +3.28% and a Zacks Rank #2 (Buy), analysts suggest the stock has a strong probability of delivering another earnings beat.

The Ensign Group expanded its skilled nursing operations by acquiring 20 facilities across Florida, Washington, and Colorado, entering Florida for the first time. With $262.3M in cash, minimal long-term debt of $135.6M, and $591.6M in available credit, the company is well-positioned for continued growth. The acquisitions bring Ensign's total portfolio to 418 healthcare operations across 18 states.

Aveanna Healthcare (AVAH) has significantly outperformed the Medical sector year-to-date, returning 56.4% compared to the sector's 2.8% average return. The company holds a Zacks Rank #2 (Buy) with consensus earnings estimates up 23.2% in the past quarter, indicating improved analyst sentiment. Charles River Laboratories (CRL) is another Medical stock outperforming with a 48.4% year-to-date return.

The Outpatient & Home Healthcare industry is experiencing rapid growth driven by digital transformation, an aging population, and cost-effectiveness advantages. The industry has a Zacks Industry Rank #52 (top 21%) with a forward P/E of 19.1X. Four key stocks are highlighted: LifeStance Health (Rank #2) with 19.7% revenue growth, Option Care Health (Rank #2) with 1.9% revenue growth, Aveanna Healthcare (Rank #2) with 10.6% revenue growth, and DaVita (Rank #3) with 4.7% revenue growth.

Aveanna Healthcare (AVAH) has surged 42.6% over the past month and hit a 52-week high of $14, outperforming its sector with a 69.2% year-to-date gain. The company has consistently beaten earnings estimates and carries a Zacks Rank #2 (Buy) with strong Growth and Momentum scores. While trading at a reasonable valuation relative to peers, the stock shows potential for continued gains in the coming weeks and months.

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced that its management team will present at the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 15, 2026 at 4:10pm CST, with 1x1 investor meetings also scheduled for that day. A webcast of the presentation will be available on the company's investor relations website.

Aveanna Healthcare completed the acquisition of Family First Homecare for $175.5 million, a multi-state pediatric home care provider. The deal prompted the company to raise its fiscal 2026 revenue guidance to $2.63-$2.65 billion (from $2.56-$2.58 billion) and adjusted EBITDA guidance to $338-$342 million (from $328-$332 million), with Family First contributing $70 million in revenue and $10 million in EBITDA.

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) completed its acquisition of Family First Homecare, a multi-state pediatric home care provider, for $175.5 million in cash. The acquisition adds 27 locations across seven states and expands Aveanna's specialized care footprint. The company updated its full year 2026 guidance, raising revenue guidance to $2.63-$2.65 billion (from $2.56-$2.58 billion) and Adjusted EBITDA guidance to $338-$342 million (from $328-$332 million), with Family First Homecare contributing $70 million in revenue and $10 million in Adjusted EBITDA.